Overview
Multifocal clinically isolated syndrome (MF-CIS) refers to a single episode of neurological symptoms affecting multiple areas of the central nervous system in individuals who have not yet met criteria for multiple sclerosis (MS). It often involves brain, inner ear, and retinal tissue, suggesting a multifocal inflammatory or ischemic process 2.Diagnosis
Clinical Presentation: Multifocal neurological deficits affecting brain, inner ear, and retina 2.
Imaging: MRI showing multifocal small hyperintensities in the brain 2.
Laboratory Tests: CSF analysis may reveal reduced levels of 5-hydroxyindoleacetic acid and homovanillic acid 2.
Ophthalmologic Evaluation: Evidence of retinal branch arteriolar occlusions 2.
Hearing Assessment: Presence of neurosensory hearing loss 2.Management
Evaluation for Underlying Causes: Investigate autoimmune disorders and coagulopathies, especially in patients on certain medications like fenfluramine 2.
Supportive Care: Address specific deficits with targeted interventions (e.g., audiology for hearing loss, neurology for cognitive deficits) 2.
Monitoring: Regular follow-up with MRI and clinical assessments to monitor disease progression 2.Special Populations
Medication Considerations: Avoid or carefully monitor use of drugs like fenfluramine that may trigger or exacerbate symptoms 2.Key Recommendations
Comprehensive Evaluation: Include MRI, CSF analysis, and ophthalmologic evaluations to diagnose multifocal involvement 2 (Evidence: Moderate).
Investigate Underlying Mechanisms: Rule out autoimmune disorders and coagulopathies, particularly in patients with potential drug triggers 2 (Evidence: Moderate).
Regular Monitoring: Schedule frequent follow-up assessments to detect early signs of disease progression 2 (Evidence: Expert opinion).References
1 Buergel T, Steinfeldt J, Ruyoga G, Pietzner M, Bizzarri D, Vojinovic D et al.. Metabolomic profiles predict individual multidisease outcomes. Nature medicine 2022. link
2 Schwitter J, Agosti R, Ott P, Kalman A, Waespe W. Small infarctions of cochlear, retinal, and encephalic tissue in young women. Stroke 1992. link